Press "Enter" to skip to content

New patent expiration for Astrazeneca Pharms drug EPANOVA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug EPANOVA

Annual Drug Patent Expirations for EPANOVA
Annual Drug Patent Expirations for EPANOVA

Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are nine patents protecting this drug.

This drug has ninety-four patent family members in forty-two countries.

The generic ingredient in EPANOVA is omega-3-carboxylic acids. Additional details are available on the omega-3-carboxylic acids profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug EPANOVA
    Do NOT follow this link or you will be banned from the site!